CDER director says FDA to take ‘close look’ at use of surrogate endpointsnews2025-09-29T19:52:17+00:00September 29th, 2025|Endpoints News|
Medicus Pharma Ltd. Receives Positive Feedback From the FDA Type C Meeting Supporting the Development of Skinjectnews2025-09-29T15:08:43+00:00September 29th, 2025|Medical Device News Magazine|
FDA Grants HemoSonics 510(k) Clearance to Expand Use of Its Quantra Hemostasis System to Obstetric Proceduresnews2025-09-29T14:55:11+00:00September 29th, 2025|Medical Device News Magazine|
Almost 30% of industry-funded research goes unpublished, new study saysnews2025-09-26T16:35:16+00:00September 26th, 2025|Endpoints News|
Crinetics gets first FDA approval as Palsonify is cleared for rare hormonal disordernews2025-09-26T07:23:39+00:00September 26th, 2025|Endpoints News|
White House weighs broad drug pricing announcementnews2025-09-25T21:10:12+00:00September 25th, 2025|Endpoints News|
Two new ARPA-H programs aim to boost genetic medicine accessnews2025-09-25T20:32:40+00:00September 25th, 2025|Endpoints News|
FDA unveils trio of new draft guidances to help cell and gene therapy developersnews2025-09-24T17:30:04+00:00September 24th, 2025|Endpoints News|
FDA warns J&J vaccine plant in South Korea following 2024 inspectionnews2025-09-23T18:54:28+00:00September 23rd, 2025|Endpoints News|
FDA’s move to update old GSK drug for autism raises questions on dose, supply and datanews2025-09-23T18:23:04+00:00September 23rd, 2025|Endpoints News|
